← FDA Drug Approvals (Drugs@FDA)

SYNCURINE

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1975-05-21

Drug application

FDA Application #

NDA006931

Application type

New Drug Application

Brand name

SYNCURINE

Generic name

Decamethonium Bromide

Active ingredients

DECAMETHONIUM BROMIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

GLAXOSMITHKLINE

First approval

1975-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown